Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | QSR | Common Shares | 5.28K | Jan 21, 2022 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | QSR | Option (Right to Buy) | Jan 21, 2022 | Common Shares | 60K | $63.64 | Direct | F1 | ||||||
holding | QSR | Option (Right to Buy) | Jan 21, 2022 | Common Shares | 15K | $66.31 | Direct | F2 | ||||||
holding | QSR | Restricted Share Units | Jan 21, 2022 | Common Shares | 3.02K | Direct | F3, F4, F5 | |||||||
holding | QSR | Restricted Share Units | Jan 21, 2022 | Common Shares | 2.84K | Direct | F5, F6, F7 | |||||||
holding | QSR | Performance Share Units | Jan 21, 2022 | Common Shares | 55.5K | Direct | F8, F9 | |||||||
holding | QSR | Performance Share Units | Jan 21, 2022 | Common Shares | 27K | Direct | F10, F11 | |||||||
holding | QSR | Restricted Share Units | Jan 21, 2022 | Common Shares | 5.69K | Direct | F5, F12, F13 | |||||||
holding | QSR | Restricted Share Units | Jan 21, 2022 | Common Shares | 5.19K | Direct | F5, F14, F15 | |||||||
holding | QSR | Performance Share Units | Jan 21, 2022 | Common Shares | 17.3K | Direct | F16, F17 |
Id | Content |
---|---|
F1 | The options were issued with an exercise price of CAD $82.81. The reported exercise price represents the U.S. dollar equivalent. |
F2 | The options were issued with an exercise price of CAD $88.03. The reported exercise price represents the U.S. dollar equivalent. |
F3 | These restricted share units vest on December 31, 2023. |
F4 | Includes 301.5259 dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. |
F5 | Each restricted share unit represents a contingent right to receive one common share. |
F6 | These restricted share units vest on December 31, 2024. |
F7 | Includes 206.5074 dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. |
F8 | Includes 5,540.7177 dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. |
F9 | The shares reported represent an award of performance base restricted share units (the "2019 PBRSUs") granted to the Reporting Person. The 2019 PBRSUs will have a performance period ending December 31, 2021 and to the extent earned will vest on February 21, 2024, which is the fifth anniversary of the grant date. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. |
F10 | Includes 1,962.2524 dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. |
F11 | The shares reported represent an award of performance based restricted share units (the "2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs will have a performance period ending December 31, 2021 and to the extent earned will vest on February 21, 2025, which is the fifth anniversary of the grant date. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. |
F12 | These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. |
F13 | Includes 283.2373 dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. |
F14 | These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. |
F15 | Includes 229.8857 dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. |
F16 | Includes 575.0574 dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. |
F17 | The shares reported represent an award of performance based restricted share units ("2021 PBRSUs") granted to the Reporting Person. The 2021 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on February 19, 2024. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. |